Aktieanalys

BioInvent: New Readout from BI-1206 Trial in Solid Tumours - Redeye

{newsItem.title}

Redeye Publicerad: 08 Jun 2023 07:28

Redeye comments on the new readout from the clinical study of BI-1206 in solid tumours, which presents additional positive clinical data.

Länk till analysen i sin helhet: https://www.redeye.se/research/915183/bioinvent-new-readout-from-bi-1206-trial-in-solid-tumours?utm_source=finwire&utm_medium=RSS

Nyheter om Bioinvent

Läses av andra just nu

Om aktien Bioinvent

Senaste nytt